<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="145928">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01200888</url>
  </required_header>
  <id_info>
    <org_study_id>SU-09092010-6830</org_study_id>
    <secondary_id>eProt #17572</secondary_id>
    <nct_id>NCT01200888</nct_id>
  </id_info>
  <brief_title>Controlled Ventilation CT in CF Infants</brief_title>
  <official_title>Differentiating Outcome Measures in Infants/Young Children With Cystic Fibrosis Utilizing Controlled Ventilation Infant/Young Child Chest CT Scanning and Lung Function Testing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the study is to implement a new method of performing chest CT imaging in
      young children with cystic fibrosis at Packard Children's Hospital. This technique will be
      used to evaluate early lung disease comparing quantitative chest CT air trapping and airway
      measurements with lung function measurements in infants, toddlers, and young children with
      chronic lung disease.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative Air Trapping, A2 &amp; A3</measure>
    <time_frame>Baseline &amp; F/U</time_frame>
    <description>Quantitative Chest CT Air Trapping by CT post-processing for Measure A2 &amp; Measure A3 (% of segmented total lung)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantitative CT Airway Measurements (AWT/TAD, LD/TAD, Wall Area %, Lumen Area %</measure>
    <time_frame>Baseline &amp; F/U</time_frame>
    <description>Quantitative Chest CT airway measurements by CT Post-Processing. AWT/TAD = Airway Wall Thickness/Total Airway Diameter LD/TAD = Lumen Diameter/Total Airway Diameter Wall Area % = Wall Area/Total Airway Area (%)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>FEV 0.5 sec</measure>
    <time_frame>Baseline &amp; F/U</time_frame>
    <description>FEV 0.5sec = % predicted</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEF 85%</measure>
    <time_frame>Baseline &amp; F/U</time_frame>
    <description>FEF 85% (% predicted)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>FEF25-75%</measure>
    <time_frame>Baseline &amp; F/U</time_frame>
    <description>FEF25-75% (% predicted)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Cystic Fibrosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Young children with cystic fibrosis at Packard Children's Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Infants and young children (age ~ 2/3 months to &lt; 5 years)

          2. Diagnosed with cystic fibrosis with either 2 identified CFTR gene mutations, or a
             positive sweat chloride

          3. Informed consent by parent or legal guardian.

          4. Ability to comply with study visit procedures as judged by the investigator.

        Exclusion Criteria:

          1. Acute wheezing and/or respiratory distress at either study visit.

          2. Acute intercurrent respiratory infection, defined as an increase in cough, wheezing,
             or respiratory rate with onset in 1 week preceding Study visit.

          3. Oxygen saturation &lt; 90% on room air at study visit.

          4. Any medical condition that in the opinion of the investigator precludes subject
             participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terry Earl Robinson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Colleen Dunn</last_name>
    <phone>(650) 736-0388</phone>
    <email>cedunn@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University School of Medicine</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Colleen Dunn</last_name>
      <phone>650-736-0388</phone>
      <email>cedunn@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Beverley Newman</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Colleen Dunn, RRT, CCRC</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rebecca Claure</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Milla</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zoe Davies RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dr. Jacquelyn Marie Zirbes DNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yan Ki Angela Leung</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Terry Earl Robinson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 14, 2012</lastchanged_date>
  <firstreceived_date>September 10, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Terry Robinson</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Cystic Fibrosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
